| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvation Bio Inc. (NUVB) has 13 insiders with recent SEC Form 4 filings, including 14 buys and 2 sells. NUVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 59.28M | $281.59M | - | |
| Dir | 350.0K | $1.66M | - | |
| Dir | 293.0K | $1.39M | - | |
| Dir | 293.0K | $1.39M | - | |
| Dir | 293.0K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Wentworth Kerry | Chief Regulatory Officer | Buy | 50,000 | $1.79 | $89,740.00 | +192.3% | +69.4% | - | |
| Jun 16, 2025 | Hung David85 | President And CEO | Buy | 500,000 | $1.79 | $893,500.00 | +0.9% | +69.4% | - | |
| May 2, 2025 | Liu Dongfang62 | Chief Medical Officer | Sale+OE | 20,000 | $2.50 | $50,024.00 | -62.5% | -4.1% | - | |
| Apr 7, 2025 | Hung David85 | President And CEO | Buy | 500,000 | $1.64 | $820,220.00 | +0.4% | +15.6% | +150.6% | |
| Apr 1, 2025 | Mashal Robert | Director | Buy | 100,000 | $1.67 | $166,985.16 | +49.7% | +11.4% | +157.7% | |
| Nov 11, 2024 | Wang Junyuan Jerry | CEO, Anheart Therapeutics Ltd. | Sell | 56,361 | $2.89 | $162,883.29 | -1.4% | -24.3% | +65.4% | |
| Oct 8, 2024 | Mashal Robert | Director | Buy | 100,000 | $2.20 | $219,999.91 | +526,316% | +27.4% | +66.8% | |
| Jun 25, 2024 | Cui Xiangmin | Director | Buy | 277,895 | $2.97 | $825,348.15 | +12.8% | -9.9% | -38.2% | |
| Jun 24, 2024 | Cui Xiangmin | - | Buy | 500,000 | $2.98 | $1,492,385.37 | +9.5% | -8.7% | -31.7% | |
| Jun 11, 2024 | Blickenstaff Kim D61 | Director | Buy | 172,189 | $2.90 | $500,088.51 | New | +4.2% | -22.8% |